In its second R&D alliance this week, Eli Lilly has formed a partnership with Genetic Leap, a startup that focuses on applying artificial intelligence to the discovery of RNA-targeted therapies.
Lilly on Wednesday announced a $4.5 billion investment to create a "medicine foundry" in Lebanon. The foundry will be located ...